Does Wegovy or Ozempic Raise Heart Rate? (Palpitations Explained)

If your resting pulse ticked up a few beats after starting Wegovy or Ozempic — or you've felt the occasional flutter — you're noticing something real, documented, and printed on the drug's own label. A small rise in heart rate is a recognized class effect of GLP-1 receptor agonists, semaglutide included. The honest version of this story has two halves that have to be held together: the heart-rate rise is real, and the same drug class lowered hard cardiovascular events in large trials. This guide explains the mechanism, the numbers, what "palpitations" actually mean here, and where a flutter stops being benign. It is general education, not medical advice for your situation — and semaglutide is prescription-only precisely because effects like this need a clinician's eye.

First, the grounding fact: Wegovy and Ozempic are both semaglutide, the same GLP-1 receptor agonist from the same maker, sold under two names for two approved uses (chronic weight management vs type 2 diabetes). We unpack that in Ozempic vs Wegovy: same drug, different label. Because it's one molecule, the heart-rate effect applies to both.

Yes — it's a real, labeled effect

This isn't an internet rumor. The FDA prescribing information for Wegovy explicitly flags an increase in heart rate as a documented effect: across trials, mean resting heart rate rose modestly versus placebo, and the label advises monitoring and considering discontinuation if a patient experiences a sustained increase¹. So the starting point is simple: a small heart-rate rise is an expected, on-label property of semaglutide, not a sign something has gone wrong.

How big is "small"? In a meta-analysis of 32 GLP-1-agonist trials, the class raised resting heart rate by about 1.9 beats per minute versus placebo². That's the average for the class as a whole. The size varies by drug and by how long the agent stays in the body: a careful review of 24-hour heart-rate monitoring found short-acting agonists nudge heart rate up only 1–3 bpm transiently, while long-acting weekly agents produce a more sustained rise — liraglutide and albiglutide at the higher end (6–10 bpm), dulaglutide lower³. Semaglutide, a once-weekly long-acting agonist, sits in that long-acting category, which is why the change tends to be steady rather than fleeting. For most people the practical reality is a resting pulse a handful of beats higher than before — measurable, but rarely dramatic.

Why does it happen? The mechanism

GLP-1 receptors aren't only in your gut and brain — they're also present in the heart and the cardiovascular system, and that's where the chronotropic ("rate-changing") effect comes from. Two mechanisms are thought to combine.

The first is a shift in the autonomic balance that sets your heart rate — the tug-of-war between the sympathetic ("accelerator") and vagal/parasympathetic ("brake") nervous systems. Human studies of long-acting GLP-1 agonists have measured a tilt in that sympatho-vagal balance consistent with a faster resting rate⁴.

The second is a direct effect on the heart's pacemaker itself. In preclinical (animal) work, GLP-1-receptor activation raised heart rate even when sympathetic nerve input was blocked — pointing to a cardiac-autonomous action at the sinoatrial node, the heart's natural pacemaker, independent of the stress-hormone pathway⁵. That mechanistic detail comes from mouse experiments, so treat it as the why, not as a human outcome — but it helps explain why the rate rise is consistent and pharmacological rather than anxiety-driven. The bottom line on mechanism: it's a built-in property of activating GLP-1 receptors, not a sign of cardiac strain.

"Palpitations" — what people actually report, and what they mean

"Palpitations" is a catch-all word for feeling your heartbeat — a thump, a flutter, a skipped beat, a racing sensation, or simply an awareness of a faster pulse. On semaglutide, several distinct things can produce that feeling, and they aren't equally concerning:

• •A higher resting rate you can now feel. A pulse that's settled a few beats faster — the labeled effect above — can make you newly aware of your heartbeat, especially lying in bed. Usually benign.
• •Dehydration-driven racing. Semaglutide's gastrointestinal side effects — nausea, vomiting, diarrhea, poor fluid intake — can leave you volume-depleted, and dehydration itself speeds the heart and triggers palpitations. This one is often fixable by addressing fluids, and it overlaps with the same dehydration pathway that can stress the kidneys, which we cover in semaglutide and your gallbladder & kidneys.
• •Low blood sugar. Palpitations, shakiness, and sweating are classic hypoglycemia symptoms. On semaglutide alone, hypoglycemia is uncommon, but the risk rises sharply if it's combined with insulin or a sulfonylurea — a reason those combinations are managed carefully.
• •An actual arrhythmia. Less commonly, palpitations reflect a true rhythm disturbance (such as atrial fibrillation) that may be unrelated to the drug. That's the category that warrants evaluation rather than reassurance.

The honest framing: most palpitations on semaglutide are the benign first two — a slightly faster baseline or transient dehydration — but the word covers a spectrum, and you can't always tell which you're having from the sensation alone.

How this sits alongside the proven heart benefit

Here's the part that confuses people most: how can a drug that raises heart rate also protect the heart? Both are true, and they're not a contradiction.

In the landmark SELECT trial, semaglutide 2.4 mg (the Wegovy dose) cut major cardiovascular events — heart attack, stroke, and cardiovascular death — by 20% in adults with established cardiovascular disease plus overweight or obesity⁶. On the diabetes side, the SUSTAIN-6 trial found a 26% reduction in those events in high-risk people with type 2 diabetes⁷, and the related GLP-1 agonist liraglutide cut cardiovascular events in the LEADER trial⁸ — all in drugs that also nudge heart rate up. We walk through the full cardiovascular case, and exactly which populations it applies to, in do Wegovy & Ozempic protect the heart? (the SELECT trial).

The reconciliation is that the modest heart-rate rise and the cardiovascular benefit are separate effects of the same drug. The few-bpm increase has not been shown to erase or outweigh the large reduction in heart attacks and strokes seen in the trials — those trials measured hard outcomes with the heart-rate effect already present, and the net result was still strongly protective. A faster resting pulse is a real pharmacological effect to monitor; it is not evidence the drug is harming the heart of the populations studied.

When a fast heart rate is benign — and when to seek care

Most of the time, a resting pulse a few beats higher is the expected, benign, labeled effect — nothing to act on beyond awareness. The situations that deserve a clinician's attention are different in kind, not just degree. While this is general education and not advice for your situation, the commonly recognized red flags include:

• •A sustained, marked rise in resting heart rate (not a few beats, but a persistent jump), which the Wegovy label itself flags as a reason to reassess the medication¹.
• •Palpitations with chest pain, shortness of breath, fainting or near-fainting, or severe dizziness — these point away from "benign awareness" and toward something needing prompt evaluation.
• •An irregular racing heartbeat (a fluttering that isn't steady), which can signal a rhythm disturbance like atrial fibrillation rather than a simple rate rise.
• •Palpitations accompanied by signs of dehydration (lightheadedness, very low urine output, intense thirst), especially during a bout of vomiting or diarrhea — fixable, but worth flagging.
• •Symptoms of low blood sugar (shakiness, sweating, confusion with the palpitations), particularly if you also take insulin or a sulfonylurea.

If you simply want to track it, a resting heart rate measured at the same time each morning gives you a baseline to compare against — useful information to bring to your prescriber. And because dose increases are the most predictable moment for new side effects of all kinds, pacing the titration matters here too: our plain guide to semaglutide dosing & side effects explains why going low and slow keeps the whole side-effect profile — heart rate included — more manageable.

The bottom line

Does Wegovy or Ozempic raise heart rate? Yes — modestly, predictably, and on-label: a class effect of GLP-1 receptor agonists, typically on the order of a few beats per minute, driven by a shift in autonomic balance and a direct pacemaker effect¹²³⁴⁵. Palpitations on these drugs are usually the benign version of that — a slightly faster baseline or transient dehydration — but the word covers a range that occasionally includes hypoglycemia or a true arrhythmia, so the sensation alone isn't diagnostic. Crucially, this rate rise coexists with a proven reduction in heart attacks and strokes in the populations studied⁶⁷⁸ — it's a thing to monitor, not a reason to assume harm. A sustained, marked increase, or palpitations with chest pain, fainting, or breathlessness, is a call-your-clinician moment, not a tough-it-out one. For the complete picture of how semaglutide works, what to expect, and the full safety profile, start with our pillar guide, Semaglutide: how it works, results & side effects. And if you're weighing providers, our editorial ranking is at the best semaglutide options, rated.